>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
蛋白赖氨酸甲基转移酶SET7/9表达对肝癌细胞增殖、凋亡和迁移的影响
作者:刘宏  顾页  蔡盈盈  余卫平 
单位:东南大学医学院 病理学与病理生理学系, 江苏 南京 210009
关键词:肝癌细胞 SET7/9 细胞增殖 凋亡 迁移 
分类号:R735.7;R318
出版年·卷·期(页码):2017·36·第三期(351-356)
摘要:

目的:探讨SET7/9表达对肝癌细胞增殖、凋亡和迁移的影响。方法:对SMMC-7721与Bel-7404肝癌细胞株分别转染SET7/9表达干扰质粒(shRNA-SET7/9)、SET7/9表达质粒(pSET7/9),采用CCK8法检测转染后24、48、72、96 h的OD值;用流式细胞术检测转染48 h的凋亡率;用Transwell实验测定细胞迁移力。结果:与对照组比较,SMMC-7721细胞转染shRNA-SET7/9后OD值呈时间依赖性下降,凋亡率增高[(26.8±3.4)%vs(11.4±3.9)%],迁移力明显降低(21.7±7.8 vs 104.8±11.3);而Bel-7404细胞转染pSET7/9后OD值呈时间依赖性增加,凋亡率下降[(8.7±3.6)%vs(16.4±3.1)%],迁移力增强(142.5±11.1 vs 104.7±10.5)。结论:肝癌细胞中SET7/9表达呈现肿瘤促进因子效应,相关机制值得深入研究。

Objective:To investigate the effect of SET7/9 expression on proliferation, apoptosis and migration in liver cancer cells. Methods:Liver cancer cell lines SMMC-7721 and Bel-7404 were transfected with shRNA-SET7/9 and pSET7/9 to reduce or induce SET7/9 expression, respectively. The cell viability was determined by CCK8 assay and OD value was measured 24, 48, 72 and 96 h after transfection. Apoptosis was determined 48 h after transfection by using flow cytometry. Migratory response of the transfected cells was examined by Transwell migration assay. Results:Compared with the control groups, cell viabilities declined time-dependently and apoptosis rate[(26.8±3.4)% vs(11.4±3.9)%] increased in SMMC-7721 cells with knockdown of SET7/9, but time-dependent raise of cell viabilities and decreased apoptosis rate[(8.7±3.6)% vs(16.4±3.1)%] were found in Bel-7404 cells with over-expression of SET7/9. The ability of migration was obviously inhibited(21.7±7.8 vs 104.8±11.3)in SET7/9 knockdown SMMC-7721 cells and enhanced(142.5±11.1 vs 104.7±10.5)in SET7/9 over-expression Bel-7404 cells. Conclusion:Our data suggest that SET7/9 functions as an tumor promoting factor in hepatic cancer cells and the related mechanism is worth further studying.

参考文献:

[1] SONG P,FENG X,ZHANG K,et al.Screening for and surveillance of high-risk patients with HBV-related chronic liver disease:promoting the early detection of hepatocellular carcinoma in China[J].Bioscience Trends,2013,7(1):1-6.
[2] ANWAR S L,LEHMANN U.DNA methylation,microRNAs,and their crosstalk as potential biomarkers in hepatocellular carcinoma[J].World J Gastroenterol,2014,20(24):7894-7913.
[3] 高丽丽,余卫平.PLMT家族成员SET7/9的非组蛋白甲基化作用[J].生命科学,2011,23(8):773-778.
[4] NISHIOKA K,CHUIKOY S,SARMA K,et al.Set9,a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation[J].Genes Dev,2002,16(4):479-489.
[5] 汪渊.蛋白甲基化修饰酶SET7/9对p53缺失人肺癌细胞的凋亡效应及其机制[D].南京:东南大学,2014.
[6] ZHOU J,XIE M,SHI Y,et al.MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells[J].Oncology Reports,2015,34(1):111-120.
[7] SONG Y,ZHANG J,TIAN T,et al.SET7/9 inhibits oncogenic activities through regulation of Gli-1 expression in breast cancer[J].Tumor Biol,2016,37(7):1-12.
[8] KURASH J K,LEI H,SHEN Q,et al.Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo[J].Molecular Cell,2008,29(3):392-400.
[9] MUNRO S,KHAIRE N,INCHE A,et al.Lysine methylation regulates the pRb tumour suppressor protein[J].Oncogene,2010,29(16):2357-2367.
[10] YOSHIMITSU A,YUKI K,SUN-JU B,et al.Reduced expression of SET7/9,a histone mono-methyltransferase,is associated with gastric cancer progression[J].Oncotarget,2015,7(4):3966-3983.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 172882 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-87232481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364